Chester County News and Community Website
MALVERN, PA — TELA Bio, Inc. (NASDAQ: TELA) has reported its financial results for the fourth quarter and full year 2024. The company showcased a year of steady growth and operational …
TELA Bio Announces 2024 Financial Results and Positive 2025 Outlook Read More
PHILADELPHIA, PA — Five Below, Inc. (NASDAQ: FIVE) reported its financial results for the fourth quarter and full year of fiscal 2024, showcasing steady growth despite a challenging retail environment. The …
Five Below Reports Fiscal 2024 Results and Outlines Growth Plans for 2025 Read More
PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) outlined a strategic pipeline re-prioritization and shared its financial results for the year 2024. This move aims to focus on potentially groundbreaking programs …
Century Therapeutics Announces Strategic Pipeline Shift and 2024 Financial Results Read More
PLYMOUTH MEETING, PA — INOVIO (NASDAQ: INO) released its financial results and operational highlights for 2024, marking significant strides in its pipeline and the broader development of DNA medicines.
INOVIO Reports Progress on INO-3107 and DNA Medicine, 2024 Financial Outcomes Read More
WILMINGTON, DE — Phreesia, Inc. (NYSE: PHR) has reported robust financial results for the fiscal fourth quarter and full year ended January 31, 2025, underscoring its continued growth and operational improvements. …
Phreesia Reports Strong Fiscal 2025 Results, Maintains Growth Outlook for 2026 Read More
WILMINGTON, DE — Global Indemnity Group, LLC (NYSE:GBLI) closed out 2024 with remarkable financial results, posting a 71% rise in net income available to shareholders, reaching $42.8 million or $3.12 per …
Global Indemnity Reports Robust 2024 Financial Performance Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has reported its financial results for the fourth quarter and full year ending December 31, 2024, marking significant progress in its turnaround …
Verrica Pharmaceuticals Reports Q4 2024 Growth and Pipeline Progress Read More
PHILADELPHIA, PA, AND NEW YORK, NY — Cohen & Company Inc. (NYSE American: COHN) has released its financial results for the fourth quarter and full year of 2024, reflecting both challenges …
Cohen & Company Reports Q4 and 2024 Financial Results Read More
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) has released its 2024 financial results and provided an update on its clinical pipeline, underscoring significant progress in its precision oncology programs. The …
Prelude Therapeutics Reports 2024 Financial Results and Clinical Pipeline Advancements Read More
HAVERTOWN, PA — AMREP Corporation (NYSE: AXR) announced a marked improvement in financial performance for its fiscal third quarter ending January 31, 2025, and the first nine months of the …
AMREP Corporation Reports Strong Q3 and Nine-Month Financial Results Read More